|
CLDX Celldex Therapeutics Inc 744218 |
| Balance Sheet |
|
Current Assets
|
778,842,000 |
|
Assets
|
823,179,000 |
|
Current Liabilities
|
32,093,000 |
|
Liabilities
|
37,274,000 |
|
Equity
|
785,905,000 |
|
Shares Out
|
66,288,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-125,302,000 |
|
Investing Cash Flow
|
-314,176,000 |
| Market Analysis |
Market Cap
|
2,809,930,899 |
|
Price
|
23.78 |
|
BVPS
|
11.86 |
|
PB
|
1.98 |
|
EPS
|
-2.74 |
|
PS
|
220.15 |
|
FCF
|
-439,478,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLDX documents filed with the SEC.
CLDX Filings
Clear
